The Conversation (0)
Feb. 28, 2014 11:47AM PST
Itonis, Inc. (PINKSHEETS:ITNS) received and is currently evaluating samples of its Emesyl™ product, an anti-nausea formula, from its manufacturer, Oasis Health Products, Inc.
Itonis, Inc. (OTCMKTS:ITNS) received and is currently evaluating samples of its Emesyl™ product, an anti-nausea formula, from its manufacturer, Oasis Health Products, Inc.
“The two versions differ in terms of preservative,” says Ernesto Barron, Itonis’ recently appointed Chief Scientific Officer. “We are looking at using a class of preservative that will not only maintain product stability but also will serve to sooth the nasal passages.”
Click here to read the Itonis, Inc. (PINKSHEETS:ITNS) press release